Panora Biosciences, Inc.

          Panora Biosciences provides quality functionalized poly(2-oxazoline), a safe, water soluble, biocompatible, non-immunogenic polymer, for scientific research and product development in academia and industry.

          Polyoxazoline has been widely studied in small molecule, protein, RNA, and antibody drug delivery, as a component in Lipid Nanoparticles (LNPs), and as an excipient in Active Pharmaceutical Ingredient (API) formulations.

          Panora Biosciences has expertise to modify drug-like compounds in molecular level. Conjugation of a biopharmaceutic polymer to a drug molecule provides a way to discover a new chemical entity (NCE) with improved pharmaceutical properties such as drug metabolism and pharmacokinetics (DMPK) and receptor binding profiles.